Kinarus Therapeutics Holding AG
SIX:CURN

Watchlist Manager
Kinarus Therapeutics Holding AG Logo
Kinarus Therapeutics Holding AG
SIX:CURN
Watchlist
Price: 11.8 CHF -2.48% Market Closed
Market Cap: 59.5m CHF

Profitability Summary

Kinarus Therapeutics Holding AG's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Past Growth

Analyzing past growth in Revenue, Operating Income, and Net Income allows investors to assess the company's profitability and operational efficiency. Consistent improvement in these metrics typically signals long-term strength and stability.

Show More Less

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Show More Less

Earnings Waterfall
Kinarus Therapeutics Holding AG

Revenue
0 CHF
Operating Expenses
-13.9m CHF
Operating Income
-13.9m CHF
Other Expenses
-6k CHF
Net Income
-13.9m CHF

Margins Comparison
Kinarus Therapeutics Holding AG Competitors

No Stocks Found

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Show More Less

Return on Capital Comparison
Kinarus Therapeutics Holding AG Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CH
Kinarus Therapeutics Holding AG
SIX:KNRS
19.5B CHF
-237%
-220%
-237%
-248%
US
Delta Air Lines Inc
NYSE:DAL
46.9B USD
29%
6%
12%
7%
US
United Airlines Holdings Inc
NASDAQ:UAL
35.7B USD
26%
4%
10%
7%
UK
International Consolidated Airlines Group SA
LSE:IAG
19.5B GBP
62%
8%
23%
10%
US
Southwest Airlines Co
NYSE:LUV
22.6B USD
4%
1%
2%
1%
IE
Ryanair Holdings PLC
LSE:RYA
15.4B EUR
29%
11%
21%
16%
IN
Interglobe Aviation Ltd
NSE:INDIGO
1.9T INR
82%
5%
15%
17%
CN
Air China Ltd
SSE:601111
147.8B CNY
1%
0%
0%
0%
CN
China Southern Airlines Co Ltd
SSE:600029
127.8B CNY
-4%
0%
4%
0%
CN
China Eastern Airlines Corp Ltd
SSE:600115
119.3B CNY
-5%
-1%
1%
1%
CL
LATAM Airlines Group SA
SGO:LTM
14.8T CLP
161%
7%
20%
15%
No Stocks Found

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

Show More Less